Trinity takes Capita herpes tests to the US:
This article was originally published in Clinica
The US FDA has cleared for sale Trinity Biotech's ELISA tests for oral and genital herpes. The Capita herpes simplex virus (HSV) tests detect IgG antibodies to HSV 1 & 2 in serum and are among the first HSV type specific ELISAs to be cleared by the agency, according to the Dublin, Ireland company. They use recombinant glycoproteins that can accurately differentiate between antibodies to types 1 and 2 of the virus, and decrease or eliminate any potential cross reactivity. In the past HSV serological testing has been limited by the inability of assays to distinguish between antibodies to HSV-1 and HSV-2, the company claimed. HSV-1 is commonly associated with oral herpes and HSV-2 with genital herpes, although both have been shown to affect either area.